Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead North America Grants support projects that aim to improve access to healthcare and education among patients and healthcare professionals. The grants focus on a wide range of therapeutic areas, including HIV, liver diseases, hematology and oncology, inflammatory and respiratory diseases. Key areas of support include: